Core Insights - As of April 17, 1695 companies have released their 2024 annual reports, with 947 reporting a year-on-year increase in net profit, while 748 reported a decline [1] - 1026 companies saw a year-on-year increase in operating revenue, whereas 669 experienced a decrease [1] - 750 companies reported simultaneous growth in both net profit and operating revenue, while 472 companies saw declines in both metrics [1] - A total of 180 companies achieved a doubling of their performance, with Zhengdan Co. leading with a staggering net profit growth of 11949.39% [1] Company Performance Summary - Zhengdan Co. (300641) reported earnings per share of 2.35 yuan, net profit of 118.99 million yuan, a year-on-year increase of 11949.39%, and operating revenue of 348.02 million yuan, up 126.31% [1] - Guangxi Energy (600310) had earnings per share of 0.043 yuan, net profit of 6.30 million yuan, a year-on-year increase of 3704.04%, but a significant decline in operating revenue by 76.48% to 393.16 million yuan [1] - North China Pharmaceutical (600812) reported earnings per share of 0.074 yuan, net profit of 12.70 million yuan, a year-on-year increase of 2496.80%, with operating revenue of 986.96 million yuan, down 2.48% [1] - Andisoo (600299) achieved earnings per share of 0.45 yuan, net profit of 120.43 million yuan, a year-on-year increase of 2208.66%, and operating revenue of 1.55 billion yuan, up 17.83% [1] - Other notable companies include Jiangsu Suopu (600746) with a net profit increase of 1029.62% and operating revenue growth of 18.43% [1] Additional Company Insights - Baoli Tianheng (688506) reported an impressive earnings per share of 9.25 yuan, net profit of 370.75 million yuan, and a remarkable year-on-year increase of 936.31% in net profit, with operating revenue of 582.27 million yuan [2] - Muyuan Foods (002714) achieved earnings per share of 3.30 yuan, net profit of 1.79 billion yuan, a year-on-year increase of 519.42%, and operating revenue of 13.79 billion yuan, up 24.43% [2] - Other companies like Xizi Clean Energy (002534) and Zhongchuan Defense (600685) reported varying performance metrics, with Xizi Clean Energy showing a decline in operating revenue by 20.33% [2]

Core Insights - Zhengdan Co., Ltd. reported exceptional financial results for 2024, with a revenue of 3.48 billion yuan, a year-on-year increase of 126.31%, and a net profit attributable to shareholders of 1.19 billion yuan, reflecting a staggering growth of approximately 11,949.30% [2][3][5] Financial Performance - The company achieved a net profit of 1.19 billion yuan and a net profit excluding non-recurring items of 1.18 billion yuan, with year-on-year growth rates of about 11,949.30% and 25,313.81% respectively [3][4] - Quarterly revenue for 2024 was reported as follows: Q1: 518 million yuan, Q2: 864 million yuan, Q3: 1.21 billion yuan, Q4: 884 million yuan, with year-on-year growth rates of 28.80%, 155.08%, 214.25%, and 115.40% respectively [3][4] - The operating cash flow net amount reached 892 million yuan, marking a year-on-year increase of 431.03% [7] Market Dynamics - The significant growth in performance is attributed to the permanent closure of TMA production lines by U.S. manufacturers, leading to a notable increase in overseas demand for Chinese TMA [5][6] - The sales volume and price of TMA, the company's main product, saw substantial increases compared to the previous year, contributing to the overall revenue growth [5][6] Operational Efficiency - The company has successfully enhanced its production capacity and efficiency, with a significant increase in the utilization rates of TMA and TOTM products, leading to reduced marginal costs and improved profitability [5][6] - The comprehensive gross margin and net margin for 2024 were reported at 41.49% and 34.19%, respectively, reflecting increases of 37.64 percentage points and 33.55 percentage points year-on-year [6] Strategic Initiatives - Zhengdan Co., Ltd. is expanding its production capabilities, with plans to invest 350 million yuan in a green upgrade project for TMA production, aimed at addressing current capacity shortages and filling market gaps [6] - The company has also initiated a project for high molecular specialty resin monomers, further diversifying its product offerings [6] Financial Health - As of the end of 2024, the company's asset-liability ratio was 8.98%, a significant decrease of 21.58 percentage points from the previous year, indicating strong financial stability [7] - The company proposed a cash dividend of 368 million yuan, with a dividend payout ratio of 30.92%, reflecting a cautious approach to profit distribution despite strong earnings [7]

Group 1 - The core viewpoint of the news is that Zhengdan Co., Ltd. (300641.SZ) has disclosed its 2024 annual report, highlighting significant institutional ownership and changes in fund disclosures [1] Group 2 - As of April 15, 2025, a total of 117 institutional investors hold shares in Zhengdan Co., Ltd., with a combined holding of 312 million shares, representing 58.57% of the total share capital [1] - The top ten institutional investors account for 58.20% of the total shares, with a decrease of 1.77 percentage points compared to the previous quarter [1] Group 3 - In the public fund sector, 111 new public funds have been disclosed this period, including Southern CSI 1000 ETF, Huaxia CSI 1000 ETF, and others [1] - One public fund, Hai Futong CSI 2000 Enhanced Strategy ETF, was not disclosed in this period compared to the previous quarter [1] Group 4 - From the perspective of foreign investment, one new foreign institution, Hong Kong Central Clearing Limited, has been disclosed this period [2] - Several foreign institutions, including Morgan Stanley & Co. International PLC, Goldman Sachs LLC, and UBS AG, were not disclosed in this period compared to the previous quarter [2]

（原标题：今日，重要发布会，事关经济！） 重要新闻 多项经济数据将公布，国新办今日上午10时将举行新闻发布会，介绍2025年一季度国民经济运行情况。 中国人民银行会同金融监管总局、中国证监会、国家外汇局联合印发《金融"五篇大文章"总体统计制度（试行）》。 工业和信息化部组织制定的强制性国家标准《电动汽车用动力蓄电池安全要求》日前发布。 3．外交部发言人林剑15日表示，消博会、广交会、中国发展高层论坛等活动的成功举行，展现了各方加强经贸合作，抵御单边主义、保护主义的 决心和信心。中国是世界的市场、各国的机遇，将以高质量发展和高水平对外开放为世界经济注入稳定性和正能量。 4．社会保险基金监管局发布2024年全国职业年金基金市场化投资运营情况。截至2024年年底，全国31个省（自治区、直辖市）、新疆生产建设兵 团和中央单位职业年金基金投资运营规模3.11万亿元。自2019年2月启动市场化投资运营以来，全国职业年金年均投资收益率4.42%。 5．4月15日，海关总署召开进出口企业、行业协会商会座谈会。会上，进出口企业和行业协会商会负责人介绍了企业、行业生产运行和稳订单拓 市场情况，并提出政策措施建议。大家一致表示，坚 ...

Core Viewpoint - Zhengdan Co., Ltd. has reported significant growth in both revenue and net profit for the year 2024, driven by its strong position in the TMA market and strategic expansion efforts [1][2]. Financial Performance - In 2024, the company achieved a revenue of 3.48 billion yuan, representing a year-on-year increase of 126.31% [1]. - The net profit attributable to shareholders reached 1.19 billion yuan, marking a staggering growth of 11,949.39% compared to the previous year [1]. - The company's stock price surged by 347.31% throughout 2024, making it a standout performer in the market [1]. Market Position and Product Focus - Zhengdan Co., Ltd. is the largest TMA supplier globally, with an annual production capacity of approximately 85,000 tons [2]. - The closure of a major TMA production facility by Ineos Joliet, which accounted for 27% of global capacity, has created a significant supply gap, benefiting Zhengdan [2]. - The company has capitalized on this opportunity, experiencing both volume and price increases for its products [2]. Industry Trends and Demand - The demand for TMA products is expected to grow, with projections indicating that the market size could reach 4.47 billion yuan by 2028 [3]. - The increasing quality requirements for TMA products driven by the development of the fine chemical industry present further growth opportunities for Zhengdan [3]. Diversification and Strategic Expansion - Zhengdan Co., Ltd. is not solely focused on TMA but is also expanding into the carbon nine aromatic hydrocarbon value chain [4]. - The company has integrated upstream raw materials efficiently, enhancing resource utilization and reducing external dependencies [4]. - Zhengdan is also developing high-value downstream products, creating a synergistic effect across its product lines [4]. - The company aims to strengthen its competitive edge through technological advancements, scale, and global delivery capabilities [4].

2024年，正丹股份实现营业收入3,480,231,502.00元，较上年同期的1,537,816,590.44元增长126.31%。从 产品结构来看，酸酐及酯类产品收入为2,789,636,533.98元，占营业收入比重80.16%，同比增长 155.11%，是营收增长的主要 驱动力 。这主要得益于美国TMA生产厂家关闭生产线，海外市场对中国 TMA需求大增，公司主要产品TMA销售数量及单价均大幅提升，同时TOTM产品销售也有所增长。从 销售地区来看，国内销售增长99.01%，国外销售更是激增212.86%，显示出公司在国内外市场的拓展均 取得显著成效。 净利润暴增，盈利能力显著提升 2025年4月16日，江苏正丹化学工业股份有限公司（以下简称" 正丹股份 "）发布2024年年度报告。报告 期内，公司多项财务数据出现大幅变动，其中归属于上市公司股东的净利润同比增长11,949.39%，经营 活动产生的现金流量净额同比增长431.03%。这两项数据的显著变化，既展现了公司在过去一年的卓越 表现，也引发了市场对其未来发展可持续性的关注。 关键财务指标解读 营收大幅增长，市场拓展成效显著 归属于上市公司股东的净利 ...

中国国际金融股份有限公司 关于江苏正丹化学工业股份有限公司 2024 年度募集资金存放与使用情况的专项核查意见 中国国际金融股份有限公司（以下简称"中金公司"、"保荐机构"）作为江 苏正丹化学工业股份有限公司（以下简称"公司"）持续督导工作的保荐机构， 根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等相 关规定，对公司 2024 年度募集资金存放与使用情况进行了核查，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 1、首次公开发行股票募集资金 经中国证券监督管理委员会《关于核准江苏正丹化学工业股份有限公司首次 公开发行股票的批复》（证监许可[2017]406 号）核准，江苏正丹化学工业股份有 限公司（以下简称"公司"）于 2017 年 4 月首次向社会公开发行人民币普通股 （A 股）7,200 万股，发行价格 10.73 元/股，募集资金总额为人民币 77,256.00 万 元，扣除发行费用 7,374.09 ...

江苏正丹化学工业股份有限公司 审计报告及财务报表 二○二四年度 江苏正丹化学工业股份有限公司 审计报告及财务报表 （2024 年 01 月 01 日至 2024 年 12 月 31 日止） | | 目录 | 页次 | | --- | --- | --- | | 一、 | 审计报告 | 1-4 | | 二、 | 财务报表 | | | | 合并资产负债表和母公司资产负债表 | 1-4 | | | 合并利润表和母公司利润表 | 5-6 | | | 合并现金流量表和母公司现金流量表 | 7-8 | | | 合并所有者权益变动表和母公司所有者权益变动表 | 9-12 | | | 财务报表附注 | 1-95 | 审计报告 信会师报字[2025]第 ZA10893 号 江苏正丹化学工业股份有限公司全体股东： 一、 审计意见 我们审计了江苏正丹化学工业股份有限公司（以下简称正丹股份） 财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公 司所有者权益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的 ...

江苏正丹化学工业股份有限公司 内部控制审计报告 2024 年 12 月 31 日 内部控制审计报告 我们的责任是在实施审计工作的基础上，对财务报告内部控制的 有效性发表审计意见，并对注意到的非财务报告内部控制的重大缺陷 进行披露。 三、 内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策 和程序遵循的程度降低，根据内部控制审计结果推测未来内部控制的 有效性具有一定风险。 四、 财务报告内部控制审计意见 我们认为，正丹股份于 2024 年 12 月 31 日按照《企业内部控制 基本规范》和相关规定在所有重大方面保持了有效的财务报告内部控 制。 信会师报字[2025]第 ZA10896 号 江苏正丹化学工业股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求，我们审计了江苏正丹化学工业股份有限公司（以下简称正丹 股份）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的 ...